{"transactions":[{"id":4635457,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-03T00:12:18.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":31908,"price":27.021,"value":862186.068,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.585 to $27.47 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":191447,"source":{"system":"sec-edgar","filing":"0001676170-26-000024","document":"form4-10022026_081010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000024/form4-10022026_081010.xml","form_type":"4"}},{"id":4635456,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-03T00:12:18.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":2593,"price":27.0241,"value":70073.4913,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.645 to $27.46 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 4 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":15558,"source":{"system":"sec-edgar","filing":"0001676170-26-000024","document":"form4-10022026_081010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000024/form4-10022026_081010.xml","form_type":"4"}},{"id":4506,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:24:27.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":129,"price":25.7749,"value":3324.9621,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units."}],"balance_after":27362,"source":{"system":"sec-edgar","filing":"0001676170-26-000022","document":"form4-09042026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1842295/000167617026000022/form4-09042026_080923.xml","form_type":"4"}},{"id":4505,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:24:27.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":11282,"price":26.0133,"value":293482.0506,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.743 to $26.65 per share, inclusive."}],"balance_after":27491,"source":{"system":"sec-edgar","filing":"0001676170-26-000022","document":"form4-09042026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842295/000167617026000022/form4-09042026_080923.xml","form_type":"4"}},{"id":4504,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:24:27.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":1375,"price":27.1211,"value":37291.5125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.055 to $27.40 per share, inclusive."}],"balance_after":38773,"source":{"system":"sec-edgar","filing":"0001676170-26-000022","document":"form4-09042026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842295/000167617026000022/form4-09042026_080923.xml","form_type":"4"}},{"id":4503,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:24:27.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":9852,"price":26.376,"value":259856.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $27.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4."}],"balance_after":40148,"source":{"system":"sec-edgar","filing":"0001676170-26-000022","document":"form4-09042026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842295/000167617026000022/form4-09042026_080923.xml","form_type":"4"}},{"id":2363,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-03T20:27:42.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The award vested or vests as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001676170-26-000020","document":"form4-09032026_080937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1842295/000167617026000020/form4-09032026_080937.xml","form_type":"4"}},{"id":2362,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-03T20:27:42.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001676170-26-000020","document":"form4-09032026_080937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842295/000167617026000020/form4-09032026_080937.xml","form_type":"4"}},{"id":2361,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-03T20:27:42.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":31908,"price":26.2876,"value":838784.7408,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.13 to $26.555 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":223355,"source":{"system":"sec-edgar","filing":"0001676170-26-000020","document":"form4-09032026_080937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842295/000167617026000020/form4-09032026_080937.xml","form_type":"4"}},{"id":2360,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-03T20:27:42.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":2593,"price":26.307,"value":68214.051,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.14 to $26.50 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 4 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":18151,"source":{"system":"sec-edgar","filing":"0001676170-26-000020","document":"form4-09032026_080937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842295/000167617026000020/form4-09032026_080937.xml","form_type":"4"}},{"id":695256,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:08:58.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":1604,"price":27.0853,"value":43444.8212,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.19 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":255263,"source":{"system":"sec-edgar","filing":"0001676170-26-000016","document":"form4-08052026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000016/form4-08052026_080854.xml","form_type":"4"}},{"id":695255,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:08:58.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":30304,"price":26.714,"value":809541.056,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.005 to $26.985 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":256867,"source":{"system":"sec-edgar","filing":"0001676170-26-000016","document":"form4-08052026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000016/form4-08052026_080854.xml","form_type":"4"}},{"id":695254,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:08:58.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":154,"price":27.094,"value":4172.476,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.16 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001676170-26-000016","document":"form4-08052026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000016/form4-08052026_080854.xml","form_type":"4"}},{"id":695253,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:08:58.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":2439,"price":26.7145,"value":65156.6655,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.01 to $26.97 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4, 5, and 7 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":20898,"source":{"system":"sec-edgar","filing":"0001676170-26-000016","document":"form4-08052026_080854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000016/form4-08052026_080854.xml","form_type":"4"}},{"id":717128,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-02T20:28:41.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":1597,"price":30.4359,"value":48606.1323,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.385 to $30.49 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are directly held by the Coloma Family Trust (the \"Family Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":287171,"source":{"system":"sec-edgar","filing":"0001676170-26-000014","document":"form4-07022026_080737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000014/form4-07022026_080737.xml","form_type":"4"}},{"id":717127,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-02T20:28:41.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":30311,"price":29.9535,"value":907920.5385,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.375 to $30.37 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are directly held by the Coloma Family Trust (the \"Family Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":288768,"source":{"system":"sec-edgar","filing":"0001676170-26-000014","document":"form4-07022026_080737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000014/form4-07022026_080737.xml","form_type":"4"}},{"id":717126,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-02T20:28:41.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":2593,"price":29.9754,"value":77726.2122,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.455 to $30.38 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 6 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust (the \"Irrevocable Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":23337,"source":{"system":"sec-edgar","filing":"0001676170-26-000014","document":"form4-07022026_080737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000014/form4-07022026_080737.xml","form_type":"4"}},{"id":727386,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:14:54.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":23865,"price":26.0496,"value":621673.704,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.185 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by the Coloma Family Trust (the \"Family Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":319079,"source":{"system":"sec-edgar","filing":"0001676170-26-000012","document":"form4-06242026_080649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000012/form4-06242026_080649.xml","form_type":"4"}},{"id":727385,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:14:54.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":2040,"price":26,"value":53040.0,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust (the \"Irrevocable Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":25930,"source":{"system":"sec-edgar","filing":"0001676170-26-000012","document":"form4-06242026_080649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000012/form4-06242026_080649.xml","form_type":"4"}},{"id":727384,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:14:54.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":1953,"price":26.0015,"value":50780.9295,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.025 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by the Coloma Family Trust (the \"Family Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":342944,"source":{"system":"sec-edgar","filing":"0001676170-26-000012","document":"form4-06242026_080649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000012/form4-06242026_080649.xml","form_type":"4"}},{"id":750782,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:04:16.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":553,"price":26.2412,"value":14511.3836,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.50 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust (the \"Irrevocable Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":27970,"source":{"system":"sec-edgar","filing":"0001676170-26-000009","document":"form4-06032026_090612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000009/form4-06032026_090612.xml","form_type":"4"}},{"id":750781,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:04:16.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":6090,"price":26.1965,"value":159536.685,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.545 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 4 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by the Coloma Family Trust (the \"Family Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":344897,"source":{"system":"sec-edgar","filing":"0001676170-26-000009","document":"form4-06032026_090612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000009/form4-06032026_090612.xml","form_type":"4"}},{"id":761225,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-27T20:16:23.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":25582,"price":26.015,"value":665515.73,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.09 per share, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by the Coloma Family Trust (the \"Family Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":350987,"source":{"system":"sec-edgar","filing":"0001676170-26-000007","document":"form4-05272026_080518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000007/form4-05272026_080518.xml","form_type":"4"}},{"id":761224,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-27T20:16:23.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":2478,"price":26,"value":64428.0,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust (the \"Irrevocable Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":28523,"source":{"system":"sec-edgar","filing":"0001676170-26-000007","document":"form4-05272026_080518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000007/form4-05272026_080518.xml","form_type":"4"}},{"id":761223,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-27T20:16:23.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":4504,"price":26.0001,"value":117104.4504,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.105 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by the Coloma Family Trust (the \"Family Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":376569,"source":{"system":"sec-edgar","filing":"0001676170-26-000007","document":"form4-05272026_080518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000007/form4-05272026_080518.xml","form_type":"4"}},{"id":774300,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:07:29.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":116,"price":26,"value":3016.0,"ownership":{"direct":false,"nature":"The Coloma 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are directly held by The Coloma 2021 Irrevocable Trust (the \"Irrevocable Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":31001,"source":{"system":"sec-edgar","filing":"0001676170-26-000004","document":"form4-05182026_090526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000004/form4-05182026_090526.xml","form_type":"4"}},{"id":774299,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:07:29.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":1822,"price":26,"value":47372.0,"ownership":{"direct":false,"nature":"Coloma Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly held by the Coloma Family Trust (the \"Family Trust\"), for which the reporting person and his spouse serve as co-trustees."}],"balance_after":381073,"source":{"system":"sec-edgar","filing":"0001676170-26-000004","document":"form4-05182026_090526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000004/form4-05182026_090526.xml","form_type":"4"}},{"id":864964,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T21:17:17.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001676170-26-000002","document":"form4-03032026_090313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000002/form4-03032026_090313.xml","form_type":"4"}},{"id":864963,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:17:17.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":45.61,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001676170-26-000002","document":"form4-03032026_090313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617026000002/form4-03032026_090313.xml","form_type":"4"}},{"id":1032801,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":1793,"kind":"person","name":"Coloma Jason V","position":1,"cik":"0001676170","reported_name":"Coloma Jason V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-09-24T20:25:47.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall vest as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001676170-25-000008","document":"form4-09242025_080943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676170/000167617025000008/form4-09242025_080943.xml","form_type":"4"}}]}